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DR. WRIGHT: As a follow-up to my formal presentation, I would like to point
out that the pathologists are quite aware of problems in diagnosing experimentally
induced emphysema in an animal model. It would be nice to be able to perform the
classical experiment, as exemplified in Pasteur's historical study of immunity to an-
thrax in sheep, one in which a direct cause and effect can be demonstrated upon
altering a single factor. Unfortunately, most of our experiments are not that straight-
forward.
DR. GROSS: I think we are all in agreement with Dr. Kleinerman that destruc-
tion of alveolar walls is a sine qua non of emphysema. It seems to me that Dr. Pratt's
criterion of emphysema-namely, the indispensable presence of unattached bands
stretching across cystically enlarged air spaces-is based on an assumption. This
assumption is that destruction of alveolar septa, when it occurs, is always incomplete
so that bands remain. As seen from Dr. Kleinerman's presentation, there are areas
of obvious emphysema where such bands are absent. Nevertheless, I agree that such
apparently unattached bands seen in lung sections are indicative of alveolar destruc-
tion. However, I do not agree when Dr. Pratt insists that when these bands are ab-
sent, there is no alveolar destructon or emphysema. To produce emphysema our ani-
mals (guinea pigs, hamsters, and rats) are exposed to high concentrations of coal
dust in an inhalation chamber. One half of the animals are given intratracheal injec-
tions of papain three months prior to the dust exposure. The dust is found collected
within alveolar spaces, generally compactly aggregated. The alveolar walls are tightly
contracted around dense dust masses. The contraction of the alveolar walls around the
dust masses appears to sequester the dust and to cause the individual particles or
macrophages to lose their identity while being compressed into masses that ultimately
represent casts of the atelectatic alveoli. It seems highly probable that the mechanism
of this sequestration is related to diffuse injury by the dust of the surfactant-secreting
alveolar lining cells. The consequential increase in surface tension of the alveolar
fluid film finally prevents the alveolus from expanding.
Sections from a guinea pig given intratracheal papain and subsequently exposed to
coal dust, reveal the sequestering atelectatic alveoli to be clustered about several
alveolar ducts. The latter are dilated, but most of their evaginating alveoli are intact.
In striking contrast, nonemphysematous tissue, with dust masses imprisoned in tightly
contracted alveoli, is found in the rat rendered emphysematous prior to the dust ex-
posure. In addition, however, a number of cystically enlarged alveolar ducts with no
or few remaining alveolar septa and having tenuous walls with abnormal communica-
tions are seen. Absence of dust in the latter region is nearly complete. There is a rela-
tive paucity of dust in the emphysematous region if the rat receives intratracheal
papain prior to coal dust exposure, although the presence of sequestrated dust may be
noticed in contracted air spaces. The paucity of accumulated dust in emphysematous
regions can be explained by the destruction of alveolar septa, causing a reduction in
the amount of surface which must be traversed by dust moving from peripheral alveoli
to reach the muco-ciliary escalator, thereby accelerating clearance. Furthermore, with
the disappearance of the evaginated alveoli of alveolar ducts (and of respiratory
bronchioles), the opportunities for stasis of peripherally moving dust particles become
diminished correspondingly. It is apparent that without alveolar septa there can be
no sequestration of dust unless the entire alveolar duct contracts around accumulated
dust, an uncommon occurrence.
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I would also like to comment on Dr. Kleinerman's findings which duplicate ours in
regard to hamsters and rats, and which were reported at the last Aspen Meeting on
Emphysema. We failed to develop any type of emphysema as the result of one year's
exposure to NO2 in hamsters or in rats. Eight per cent of our guinea pigs, however,
developed microfocal bullous emphysema.
DR. PRATT: I think it is worthwhile to mention that emphysematous lungs are
seen not only at the end of a long period of complaints but also before the patient evi-
dences any complaints. We know the emphysema is there, and it consists of fenestra-
tions in the alveoli. Therefore, we are not seeing the terminal stage and saying that
we ought to look only for fenestration; but the disease does start out with fenestra-
tion.
DR. VORWALD: Some six years ago, with the support of the Public Health
Service, we embarked upon a large experiment of long-term exposure of rats, guinea
pigs, rabbits, and hamsters to dirty air. We had two room-sized chambers, one of
clean air and one of dirty air. The latter contained ambient air drawn off the streets
in downtown Detroit at 14,000 cubic feet a minute. To be as realistic as possible,
recognizing the possibility of a genetic influence, we apportioned siblings of each sex
into both rooms. The animals, studied through four generations, were sacrificed
periodically. Pulmonary function studies of the guinea pigs, rats, and rabbits were
made. Throughout the total experiment, day and night, 13 different ambient air
components (carbon dioxide, carbon monoxide, hydrocarbons, ozone, nitrogen dioxide,
sulfur dioxide) were persistently monitored. The components varied according to the
day of the week and the time of day, being highest at traffic peaks and lowest over the
weekend when there was relatively little traffic. Results of the study revealed there to
be no significant pulmonary change over the six-year period of study.
DR. FREEMAN: I should like to ask Dr. Wright for his definition of hyperinfla-
tion. I am not certain whether he was talking about hyperinflation in the natural state
post mortem, or whether it was hyperinflation as seen after filling of the lung. Was he
also talking about naturally bulging lungs immediately post mortem, or inflatability?
DR. WRIGHT: I think the hyperinflation that I showed in those first two pictures
of the NO2 experiment were really focal areas of hyperinflation which more than
likely were artifacts. One sees lungs with diffuse obstruction that do overinflate, but
there is no destruction of the alveolar septa. This you see quite commonly in the
human who dies from acute asthma. The preparation of the lung is extremely im-
portant. If the lung is uniformly filled, the hyperinflation will be seen simply as over-
ly large alveoli uniform in size throughout the entire organ, whereas if it is a local
effect from poor fixation or poor inflation, over-stretching of the alveoli, accompanied
by or adjacent to collapsed lungs, will be seen. These changes, to my mind, may be
an artifact.
DR. FREEMAN: I wondered when you used the term "hyperinflation" whether
you were referring to hyperinflation after or before filling of the lung. In other words,
are you referring to hyperinflated lungs as they exist in a freshly-opened chest, or to
hyperinflation as caused by filling the removed, intact lung in the process of fixation?
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DR. WRIGHT: I think both. They can be overinflated by disease or by overfilling
with fluid or by excessive pressure.
DR. SAFFIOTTI: We find it very satisfactory to tie the trachea before opening
the chest cavity, even in small animals such as rats and hamsters. The lung should
not be touched but placed where it will be fixed by capillarity without the air content
being disturbed. Once it is fixed it can be dissected out while gently pulling on the
esophagus with a forcep; then the sections can be cut.
DR. WRIGHT: I would disagree. This is a nonuniform process which will result
in an artifactual picture. We inflate with 25 to 37 liters of air without encountering
leaks, and in this way maintain a uniform inflation. Fluid is not good because it will
leak out unless run at a constant pressure into the lung over a period of 48 to 72 hours.
DR. SAFFIOTTI: We retain all the air normally present in the lungs at the time
the animal is anesthetized. It is important to tie the trachea so that no air escapes. We
are presently studying this problem, hoping to eliminate serious artifacts.
DR. KLEINERMAN: I think perhaps we can save Dr. Saffiotti some work since
some years ago Dr. Cowdrey and I did such a study comparing inflation techniques.
We found that the pure intravascular fixation without controlling intratracheal pres-
sure led to tremendous distortions and artifacts that made the pathology very difficult
to interpret.
DR. MACNAMEE: I think it has been very revealing that not only is there little
agreement on the model system, but there is a tremendous disagreement on the proper
fixation of the experimental lung.
DR. TYLER: I think we are pretty well agreed that the lung should be continuous-
ly fixed via the trachea or bronchi at 20 to 30 centimeters of pressure over a minimum
period of three days, although Dr. Wright recommends 48 to 72 hours.
DR. HAYDON: The question is not whether we have emphysema, but to evaluate
the degree and the type of emphysema. Also, what are we going to use as criteria of
destruction?
DR. PRATT: I mentioned isolated strands seen in histological sections of lungs,
but this is not the way to demonstrate the presence of tissue destruction in emphy-
sema. The presence of fenestrations in the thick sections of an inflated specimen indi-
cates emphysema.
DR. MYRVIK: I would like to ask Dr. Kleinerman, with regard to the lesions he
found in animals following exposure to 40 to 55 ppm NO2, whether he thinks the
lesions result from primary toxicity of NO. or from infections? Do you have any
notion that these animals become tolerant to the gas? I believe this has been reported
for the lethal concentrations for some of these gases.
DR. KLEINERMAN: In response to your first question, I think this is chiefly
the effect of NO, and not infection. I base this on the fact that the majority of these
lesions resolve without any therapy except removal of the NO. If you place an animal
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in the gas at a certain level, it carries a slightly higher concentration to evaluate
when transferred to lower levels. We must establish reasonable criteria to evaluate
tolerance based on a tissue reaction rather than merely survival.
DR. ABINANTI: Dr. Thomas noted the effects of mycoplasma infections on lymph-
ocytes. Would Dr. Gross or Dr. Kleinerman wish to comment on the possibility of
gassing in conjuction with mycoplasma infections, hoping such a regimen would pro-
duce a more irreversible change?
DR. KLEINERMAN: We will be glad to try it. I have no way of predicting what
would happen, but it would be an interesting experiment to do.
DR. CARRINGTON: I would just like to elaborate on the reasons for prolonging
fixation. Dr. Brian Heard discussed this in some detail a few years ago. It is true that
cells are adequately fixed quickly. There is considerable shrinkage of the lung volume
and hence in the size of individual air space if the intact lung is not kept under pro-
longed tension for several days. A week is preferable to any shorter time, although
three days is sometimes adequate. The fixative used makes a difference. For example,
formalin is much slower in fixing the lung to the point where it will no longer col-
lapse as compared to gluteraldehyde (1.7 to 3.5 per cent) which is more rapid and
gives a stiffer lung which does not collapse after a shorter period of fixation. Zenker's
solution causes the tissue to harden before it is fully inflated. For routine light mi-
croscopy it is not necessary to employ immersion in buffer. It is preferable to use a
buffer for a few of the special stains, particularly those for AFB.
DR. TYLER: In using gluteraldehyde of 1.5 per cent we adjust the milliosmolarity
to approximately 300. We find this penetrates rapidly and fixes the tissue in about
four hours with very good preservation of structure and of some enzymes.
DR. MUELLER: Most of the nitrogen dioxide in the atmosphere first results from
the oxidation of nitrous oxide. Perhaps this explains why some people regularly ex-
posed to cigarette smoke do not encounter difficulty.
One item that intrigues me are the results, described briefly by Dr. Boren, of the
sequential changes. Atmospheric concentrations of 0.15 ppm ozone are exceeded in Los
Angeles only 10 per cent of the total time per year, suggesting a tremendous change in
the sequence of exposure. These concentrations are at least one order of magnitude
less than those we have been considering. According to Dr. Kleinerman, even 25 or
50 ppm NO2 does not seem to induce emphysema. Nevertheless, NO2 does produce
changes in the tissue. I am wondering therefore, what motivates continued studies on
the effects of low concentrations of NO3 on lung tissue.
DR. KLEINERMAN: I think we should not be so narrow as to focus our attention
only on emphysema. What we are really interested in, and I hope I speak for all
pathology-oriented persons, is the reaction of the lung tissue to injury and how it
repairs itself. Along with this type of information, I think we can make a meaningful
approach to the next problem, which is how do we destroy tissue.
DR. FREEMAN: I wanted to make the comment that these concentrations which
are being used with nitrogen dioxide are not standard. For instance, it has been our
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experience that more advanced lesions are found in animals exposed to 12 ppm than
in those exposed to 25 ppm NO2. We wish to avoid inflammatory reaction and edema
so that other kinds of cellular responses are not overwhelmed by the inflammatory
response. This is the objective of using very low concentrations rather than the high
concentrations which Dr. Kleinerman has discussed.
DR. KLEINERMAN: As far as low levels of nitrogen dioxide being more con-
sistent with the human experience, this depends on what one is trying to do. It is
necessary to explore the system in all ways since we do not know all the variables,
either of total response or of tissue reactions.
DR. FREEMAN: We were not trying to aim at NO, levels humans encounter. We
started with a killing concentration and kept decreasing it until tissue reaction was
inapparent in the entire lifetime of the animal.
DR. LOOSLI: We are presently exposing germ-free as well as pathogen-free ani-
mals to the higher concentrations of NOs simply to hasten appearance of the lesion
so we can study it. There does appear to be a relationship in the germ-free animal
between concentration and rapidity with which these lesions appear, as Drs. Freeman
and Kleinerman have demonstrated.
DR. KILBURN: I think most people do not need to be reminded that a big dose
over a short time is not the same as a small dose over a long time. The thing we need
to consider is host factors and how adaptation alters host responses.
DR. MACNAMEE: Since Dr. Kleinerman is employing a 2-hour day, 5-day week
high concentration exposure and Dr. Freeman is employing a 24-hour day, 7-day week
exposure at low concentrations, it is obvious that their objectives and lesions produced
will vary considerably. Moreover, they are not using the same animal model.
590